Reprogenetics

Experts in Preimplantation Genetic Diagnosis

Abstract

This study retrospectively analysed array comparative genomic hybridization (CGH) results of 7753 embryos from 990 patients to determine the frequency of embryonic euploidy and its relationship with the cohort size (i.e. the number of embryos available for biopsy and array CGH analysis). Linear regression analysis was performed to assess the effect of cohort size on euploidy rate adjusted for the effect of female age. While increasing female age was associated with a significant decrease in euploidy rate of day-3 and day-5 embryos (P < 0.001 for both groups), cohort size was not significantly associated with euploidy rate. Logistic regression analysis was performed to assess the effect of cohort size, adjusted for maternal age, on the likelihood of having at least one euploid embryo available for transfer. The odds of having at least one euploid embryo in an assisted cycle was significantly decreased by increasing female age (P < 0.01 for both day-3 and day-5 embryos) and was significantly increased by every additional embryo available for analysis (P < 0.01 for both day-3 and day-5 embryos).

 

To Purchase Text or find more information –> Click here

Posted by admin On April - 9 - 2012 news slider

Congratulations to Dagan Wells, PhD and Reprogenetics for winning the SART Prize Paper at the 67th Annual Meeting of the American Society for Reproductive Medicine (ASRM) in Orlando, FL
view here

Posted by admin On October - 18 - 2011 news slider

Researchers at Reprogenetics have published a study demonstrating the high accuracy of a new technique, called array CGH (aCGH), for analysis and screening of all chromosomes in human embryos. The authors report that errors or potential misdiagnoses occur very rarely with this technique. In the case of individual blastomeres from day-3 embryos, the error rate is only 1.8%, despite complications arising from mosaic embryos; these are embryos with a mix of normal and abnormal cells. They are known to occur frequently in vitro and can cause non-technical diagnostic errors during PGD. Further research at Reprogenetics has shown the accuracy of aCGH for blastocyst (day-5) biopsies to be 100% (unpublished data). This is clearly very encouraging.

The error rate published by Gutierrez and co-workers was obtained through the full analysis of all blastomeres in embryos that were previously analyzed and excluded from transfer based on chromosomal and other abnormalities; the results of the reanalysis were then compared with the original results obtained based on analysis of one (day-3) or a few cells (day-5). The 1.8% error rate indicates that only 2 of every 100 embryos had discordant results, that is, they were classified as abnormal but were not entirely abnormal; none of those classified as normal was found to be abnormal.

Many laboratories do not publish error rates which is problematic because they have no reference point for the results they produce. In our view, reanalysis of embryos using either the same technique or another technique as a quality control measure is critical for genetic testing laboratories. Implementation of such Quality Control/Quality Assurance measures sets Reprogenetics apart from many of its competitors.

“We now think that although mosaicism is very common in human embryos, a majority of mosaic embryos are what we call chaotic mosaics, resulting from a random distribution of chromosomes from cell division to cell division. Analysis of all chromosomes in every cell in these embryos shows that the likelihood of one cell having a normal chromosome count is slim to none. With previous techniques, not all chromosomes were analyzed; some cells appeared to be normal for the chromosomes analyzed, suggesting that mosaic embryos could produce a misdiagnosis.” Comments Santiago Munné, President of Reprogenetics and senior author on the article.

For more information: PubMed

1 Gutierrez-Mateo et al. Fertility and Sterility, 2011, 95:953-958

Posted by admin On August - 10 - 2011 news slider
Reprogenetics offers Products of Conception to help couples get a better picture of  how they might respond to IVF Fertility treatments. Based on a number of genetic and cytogenetic factors, Reprogenetics is able to uniquely predict IVF outcome based on the historical data of thousands of other couples who have been helped by our laboratory.
Posted by admin On May - 12 - 2011 slider
Array CGH testing allows for the detection of all 24-chromosome type aneuploidies in human embryos (either by Polar Body, day 3, or blastocyst biopsy). At Reprogenetics, having performed >1,500 cases of aCGH testing allows us to provide you with the prognosis of replacing normal embryos depending on the number of embryos produced and the age of the patient. This can be handy to decide whether to recommend Preimplantation Genetic Diagnosis, egg donation, and/or help patients transition to egg donation through a PGD cycle.

Day 3 Prognosis Depending on Age and Ovarian Response

The chart pictured to the left helps to determine, on average, the percentage of normal embryos (percentage, bold) retrieved for patients given their maternal age and the total number of embryos retrieved. 

The chart is also helpful for estimating the average pregnancy rate for patients in each age group (percentage, italicized). Green groups are patients with the highest likelihood for success whereas red groups are patient groups with the lowest likelihood for success. Note: The data is as of 2/2011, representing 609 IVF Cycles, 5101 embryos.

 

 


Prognosis Depending on Age and Ovarian Response After Day 5 Biopsy

Array CGH also allows for the detection of all 24-chromosome type aneuploidies from blastocyst biopsies. Results are available in <24 hours after sample reception.

Having performed >100 cases of Array CGH on day-5 blastocyst biopsies alows us to provide you with the prognosis of replacing normal embryos depending on the number of embryos produced and the age of the patient. The chart to the right summarizes these results.

Posted by admin On January - 19 - 2011 slider